CeNeS Pharmaceuticals, the Cambridge biotech company, is to begin Phase II clinical trials on a treatment for alcohol abuse, a potential cure which is exciting analysts.
Marketing specialists Ware Anthony Rust Ltd, have been nationally recognised for commitment to staff development.
SecurityOne is pleased to announce the appointment of Greenfield Ventures; the specialist technology start up headhunting company to source a group of key board members to aid in the ongoing development of its business, Tim Taylor the CEO of Greenfield Ventures is currently Chairman for the group.
Cambridge Graduate Recruitment has launched a specialist program for graduate employers in the UK.
MPs greeted Chancellor Gordon Brown's Budget with a mixture of delight and fury.
Cambridge has to find ways of accommodating its boom, otherwise firms will go to Munich or Boston instead, warned Lord Sainsbury, science minister, who was at Granta Park this week.
Cambridge software firm Autonomy and logistics group Exel are to drop out of the FTSE-100 following the blue-chip index's quarterly reshuffle, it was announced.
Sparks in telecom and banking shares kept the FTSE-100 with its head just above water yesterday (Thursday).
Amarin Corporation in Ely, the life sciences business, posted total revenues of 8.
Pharmagene, the Royston based human tissue company, has signed a drug discovery agreement with Bayer plc in the area of respiratory disease.
One of the world's leading scientists in the area of surface engineering is joining Keronite Ltd of Cambridge, whose technology is tilting at global markets that could be worth billions.
Software giant Microsoft is using the appliance of science to cut fuel bills - its new 10 million Euro research lab will be heated only by its computers.
It was top billing for Geneva Technology with news that the Cambourne company has agreed a half a billion pound merger with the world's largest billing services company.
Celltech has signed the biggest product deal in the history of European biotech.
Tech shares fell back yesterday (Wednesday) following previous strong gains, causing a subdued start to trading.
A Cambridge genetics instrumentation company has been sold for an undisclosed sum to Apogent Technologies Inc, a listed US manufacturer of laboratory and life science products.